Our Latest News

  • New School of Medicine study identifies novel mechanisms that cause protein clumping in Alzheimer's and other degenerative brain diseases

    A team of researchers at Case Western Reserve University School of Medicine has taken a major step toward understanding the mechanisms involved in the formation of large clumps of tau protein, a hallmark of Alzheimer’s disease and several other neurodegenerative disorders.
  • H. Jack Geiger, public health pioneer, passes away

    Case Western Reserve University alumnus H. Jack Geiger, MD (MED ’58, HON ’00), who used his medical training and experience to take on poverty, racism and the threat of nuclear destruction, was considered a pioneer in the development of community health centers across the United States. He also made his mark internationally: Two advocacy groups he helped launch each won Nobel Peace Prizes. Geiger died Dec. 28 at his home in Brooklyn, New York. He was 95.
  • 5 questions with… Johnie Rose, preventive medicine and public health researcher applying work to COVID-19

    When the COVID-19 pandemic began, Johnie Rose was uniquely positioned to support the local response. An assistant professor at Case Western Reserve University’s School of Medicine in the Center for Community Health Integration and director of the Preventive Medicine Residency Program, Rose has a long-standing relationship with the Cuyahoga County Board of Health and was an obvious choice to join a response team assisting the board’s efforts.
  • Four School of Medicine Employees Honored with Staff Awards for 2020

    As we transition to a new year, the School of Medicine is very pleased to congratulate four employees who were honored with Staff Awards for 2020: John Pounardjian, Erin Fogarty, Michelle Shaylor and Kacie Wick. These awards, the highest the school can bestow upon staff members, celebrate four individuals who not only have consistently performed their duties in an outstanding manner, but steadily operate with an exemplary attitude and strong support of their colleagues and their department.
  • Case Med Pride awarded MSPA Chapter of the Year 2021

    Congratulations to Case Med Pride, the School of Medicine's LGBTQ+ student organization, recently winning the Chapter of the Year Award for 2021 through the Medical Student Pride Alliance (MSPA). The award recognizes an outstanding national chapter's achievements that exemplify the mission of MSPA.  
  • Newly diagnosed cancer patients, African Americans more at risk for COVID-19 infection

    Cancer patients, especially newly diagnosed and African American patients, are significantly at risk for COVID-19 infection, hospitalization and mortality, according to a new study published in JAMA Oncology by researchers from Case Western Reserve University School of Medicine and the Case Comprehensive Cancer Center. 
  • Case-Coulter Translational Research Partnership awards $1.1 million in funding and support for promising biomedical engineering university technologies

    The Case-Coulter Translational Research Partnership has announced more than $1.1 million in funding and other support for six biomedical technologies out of Case Western Reserve University. The six projects were selected for full program funding, which ranges from $50,000 to $200,000 each. Several additional pilot projects have been or will be awarded funding by the end of the year. All projects are partnerships between a clinician and a biomedical engineer, and are focused on solving areas of unmet health care needs.
  • Cliff Harding Awarded Case Medal for Excellence in Health Science Innovation

    During a virtual ceremony on December 4, Stan Gerson, interim dean for the School of Medicine, awarded Cliff Harding the Case Medal for Excellence in Health Science Innovation. Harding was recognized for his groundbreaking research, skilled department management, and deep dedication to his students with the highest honor bestowed by the School of Medicine.
  • Student Spotlight - Madeline McKenna

    Growing up in Dayton, Ohio, Maddie McKenna originally thought she would become a photojournalist. That changed when, as a teenager, she accompanied her father (a 1992 School of Medicine alumnus) and a group of volunteer medical professionals to Honduras to partner with health organizations in the local community. “The experience completely sparked my interest and passion for medicine,” she said. 
  • Case Western Reserve University researchers study how the immune system responds to COVID-19

    School of Medicine awarded $2.6M; receives two of 13 grants nationally

    New research funded by the National Cancer Institute (NCI) aims to boost understanding of how the immune system responds to COVID-19, from the start of infection to recovery. Two projects totaling over $2.6 million are being led by Case Western Reserve University and Cleveland Clinic researchers as part of the NCI’s Serological Sciences Network (SeroNet), which awarded just 13 grants nationally.

  • Cleveland Center for Membrane and Structural Biology Makes Breakthrough Neurological Discoveries

    Sudha Chakrapani and her team of researchers understand that exploring the smallest molecular structures requires advanced instrumentation, big data and state-of-the-art shared resources. Recently appointed Director of the Cleveland Center for Membrane and Structural Biology (CCMSB), Chakrapani’s team is discovering breakthroughs in the new Cryo-EM Core facility, home to the first cryo-electron microscope in the Greater Cleveland area.
  • Student Spotlight - Caroline Schuerger

    Blazing trails by blending hard science with public health and social policy

    Caroline Schuerger is serious about combining medical research and science advocacy to advance public health. After earning her undergraduate degree at University of North Carolina, Chapel Hill, she enrolled in the Cleveland Clinic Lerner College of Medicine (CCLCM), studying translational hematology and oncology research. 

  • UH and CWRU announce clinical trial of AstraZeneca's COVID-19 vaccine candidate

    University Hospitals (UH) and Case Western Reserve University (CWRU) announced recently that UH Cleveland Medical Center has been selected as a clinical trial site for the Phase 3 global study of an investigational vaccine against SARS-CoV-2, sponsored by AstraZeneca (LSE/STO/NYSE: AZN). The trial is funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, and the Biomedical Advanced Research and Development Authority (BARDA), part of the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response. UH is part of the NIAID-supported COVID-19 Prevention Network (CoVPN). UH will study AZD1222 as one of approximately 80 clinical investigational sites in the U.S. that will collectively enroll up to 30,000 participants.  
  • Using AI to improve heart-transplant outcomes

    Madabhushi lab working with researchers from Perelman School of Medicine at University of Pennsylvania, Cleveland Clinic and Cedars-Sinai Medical Center to begin training computers to glean from pathology images which patients will accept, reject heart transplant The team of biomedical researchers at the Center for Computational Imaging and Personalized Diagnostics (CCIPD) has tackled various aspects of lung cancer, breast cancer, colon cancer and more since the center was launched at Case Western Reserve University in 2012 by bioengineering pioneer Anant Madabhushi.
  • New research reveals why low oxygen damages the brain

    Researchers uncover surprising dark side to the body’s normally protective low oxygen response system Brain cell dysfunction in low oxygen is, surprisingly, caused by the very same responder system that is intended to be protective, according to a new published study by a team of researchers at Case Western Reserve University School of Medicine.